Ahmed R. Gardouh

Dr. Ahmed R. Gardouh

Pharmaceutics and industrial Pharmacy, Faculty of pharmacy, Suez Canal University, Ismailia, Al Ismā‘īlīyah, Egypt
+1
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2016 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Ali NasrAli Nasr
Ali Nasr
Ahmed R. GardouhAhmed R. Gardouh
Ahmed R. Gardouh
MGMamdouh Ghorab
Mamdouh Ghorab
The main purpose of this study was to develop a solid self-nanoemulsifying drug delivery system (S-SNEDDS) of Olmesartan (OLM) for enhancement of its solubility and dissolution rate. In this study, liquid SNEDDS containing Olmesartan was formulated and further developed into a solid form by the spray drying technique using Aerosil 200 as a solid carrier. Based on the preliminary screening of different unloaded SNEDDS formulae, eight formulae of OLM loaded SNEEDS were prepared using Capryol 90, Cremophor RH40 and Transcutol HP as oil, surfactant and cosurfactant, respectively. Results showed that the mean droplet size of all reconstituted SNEDDS was found to be in the nanometric range (14.91–22.97 nm) with optimum PDI values (0.036–0.241). All formulae also showed rapid emulsification time (15.46 ± 1.34–24.17 ± 1.47 s), good optical clarity (98.33% ± 0.16%–99.87% ± 0.31%) and high drug loading efficiency (96.41% ± 1.20%–99.65% ± 1.11%). TEM analysis revealed the formation of spherical and homogeneous droplets with a size smaller than 50 nm. In vitro release of OLM from SNEDDS formulae showed that more than 90% of OLM released in approximately 90 min. Optimized SNEDDS formulae were selected to be developed into S-SNEDDS using the spray drying technique. The prepared S-SNEDDS formulae were evaluated for flow properties, differential scanning calorimetry (DSC), scanning electron microscopy (SEM), reconstitution properties, drug content and in vitro dissolution study. It was found that S-SNEDDS formulae showed good flow properties and high drug content. Reconstitution properties of S-SNEDDS showed spontaneous self-nanoemulsification and no sign of phase separation. DSC thermograms revealed that OLM was in solubilized form and FTIR supported these findings. SEM photographs showed smooth uniform surface of S-SNEDDS with less aggregation. Results of the in vitro drug release showed that there was great enhancement in the dissolution rate of OLM. To clarify the possible improvement in pharmacokinetic behavior of OLM S-SNEDDS, plasma concentration-time curve profiles of OLM after the oral administration of optimized S-SNEDDS formula (F3) were compared to marketed product and pure drug in suspension. At all time points, it was observed that OLM plasma concentrations in rats treated with S-SNEDDS were significantly higher than those treated with the drug in suspension and marketed product.

1 January 2017 in Research in Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
SSSherif Shaker
Sherif Shaker
Ahmed R. GardouhAhmed R. Gardouh
Ahmed R. Gardouh
MGMamdouh Mostafa Ghorab
Mamdouh Mostafa Ghorab
Ethanol injection is one of the techniques frequently used to produce liposomes which favors both simplicity and safety. In this process, an ethanolic solution of lipids is rapidly injected into an aqueous medium through a needle, dispersing the phospholipids throughout the medium and promoting the vesicle formation. Being a critical parameter that determines the fate of liposome and its distribution, we studied different factors affecting the particle size of liposomes including different phospholipid (Phosal® 53 MCT) and cholesterol concentrations and the use of different types of non-ionic surfactants at fixed Phosal® 53 MCT concentration of 50 mg per formulation. Both Phosal® 53 MCT and cholesterol concentration had direct effect on liposomes particle size. Non-ionic surfactants produced liposomes of smaller particle size when compared to conventional liposomes formed using Phosal® 53 MCT 300 mg per formulation only, whereas this effect was diminished when higher Phosal® 53 MCT to cholesterol ratios were used that obviously increased liposomes size. Smaller liposomes sizes were obtained upon using non-ionic surfactants of lower hydrophilic/hydrophobic balance (HLB) as both Tween 80 and Cremophor RH 40 produced liposomes of smaller particle size compared to Poloxamer 407. The smallest liposomes particle size was successfully obtained in the formulation comprising 300 mg Phosal® MCT, 150 mg cholesterol and 50 mg Tween 80.

1 December 2020 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
Ahmed R. GardouhAhmed R. Gardouh
Ahmed R. Gardouh
ANAhmed M. Nasef
Ahmed M. Nasef
YMYasser Mostafa
Yasser Mostafa
Shadeed GadShadeed Gad
Shadeed Gad

1 December 2017 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
ANAhmed Mohammed Nasef
Ahmed Mohammed Nasef
Ahmed R. GardouhAhmed R. Gardouh
Ahmed R. Gardouh
MGMamdouh Moustafa Ghorab
Mamdouh Moustafa Ghorab
The pH-sensitive polymeric nanoparticles are very efficient delivery systems for acid labile drugs. The main aim of the study was to formulate pantoprazole loaded pH-sensitive polymeric nanoparticles using pH-sensitive polymers to prevent degradation of acid labile drug and evaluate the effect of formation conditions on both nanoparticles characteristics and drug release patterns. Pantoprazole loaded nanoparticles were prepared using nanopercipitation method using pH-sensitive polymers Eudragit S100 or HPMC phthalate HP55. Nanoparticles were characterized for their micromeritic and crystallographic properties, drug content, in-vitro release and the ability to delay pantoprazole release in acidic medium to prevent its degradation. Physicochemical properties of nanoparticles, including particle size, loading capacity (LC), encapsulation efficiency (EE) and in-vitro drug release were significantly affected by formulation conditions. All formulas showed sub micronized size ranging from 299.3 ± 4.62 to 639.7 ± 9.71 nm and achieved delayed release to protect pantoprazole from degradation with different degrees, but generally Hydroxypropyl methyl cellulose phthalate HP55 loaded nanoparticles showed slower drug release than that of Eudragit S100 loaded nanoparticles. Release kinetics and morphological properties of nanoparticles with most delayed release pattern were investigated by Transmission Electron Microscope (TEM) and Compatibility between pantoprazole and polymer was proved by Fourier Transmission Infra Red (FT-IR) and Differential Scanning calorimetry (DSC). The formula stability was evaluated by measuring zeta potential value. Our results suggested that nanoprecipitation method is effective to produce pH-sensitive polymeric nanoparticles, which can be used as a delivery system for acid labile drug (Pantoprazole) to avoid its degradation in acidic medium of the stomach

15 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Ahmed R. GardouhAhmed R. Gardouh
Ahmed R. Gardouh
MAMohammed A. Attia
Mohammed A. Attia
EEEman Enan
Eman Enan
AEAlaaeldeen M. Elbahaie
Alaaeldeen M. Elbahaie
RFRania A. Fouad
Rania A. Fouad
MQMona Kamel Eed Qushawy
Mona Kamel Eed Qushawy
Objectives: The aim of this study was to prepare doxycycline polymeric nanoparticles (DOXY-PNPs) with hope to enhance its chemotherapeutic potential against solid Ehrlich carcinoma (SEC). Methods: Three DOXY-PNPs were formulated by nanoprecipitation method using hydroxypropyl methyl cellulose (HPMC) as a polymer. The prepared DOXY-PNPs were evaluated for the encapsulation efficiency (EE%), the drug loading capacity, particle size, zeta potential (ZP) and the in-vitro release for selection of the best formulation. PNP number 3 was selected for further biological testing based on the best pharmaceutical characters. PNP3 (5 and 10 mg/kg) was evaluated for the antitumor potential against SEC grown in female mice by measuring the tumor mass as well as the expression and immunohistochemical staining for the apoptosis markers; caspase 3 and BAX. Results: The biological study documented the greatest reduction in tumor mass in mice treated with PNP3. Importantly, treatment with 5 mg/kg of DOXY-PNPs produced a similar chemotherapeutic effect to that produced by 10 mg/kg of free DOXY. Further, a significant elevation in mRNA expression and immunostaining for caspase 3 and BAX was detected in mice group treated with DOXY-PNPs. Conclusions: The DOXY-PNPs showed greater antitumor potential against SEC grown in mice and greater values for Spearman’s correlation coefficients were detected when correlation with tumor mass or apoptosis markers was examined; this is in comparison to free DOXY. Hence, DOXY-PNPs should be tested in other tumor types to further determine the utility of the current technique in preparing chemotherapeutic agents and enhancing their properties.

3 March 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
RAReem Alshaman
Reem Alshaman
AAAbdullah Alattar
Abdullah Alattar
RERehab m. El-Sayed
Rehab m. El-Sayed
Ahmed R. GardouhAhmed R. Gardouh
Ahmed R. Gardouh
RERabie E. Elshaer
Rabie E. Elshaer
SZSawsan Zaitone
Sawsan Zaitone
Nanotherapeutics can enhance the characteristics of drugs, such as rapid systemic clearance and systemic toxicities. Polymeric nanoparticles (PRNPs) depend on dispersion of a drug in an amorphous state in a polymer matrix. PRNPs are capable of delivering drugs and improving their safety. The primary goal of this study is to formulate doxycycline-loaded PRNPs by applying the nanoprecipitation method. Eudragit S100 (ES100) (for DOX-PRNP1) and hydroxypropyl methyl cellulose phthalate HP55 (for DOX-PRNP2) were tested as the drug carrying polymers and the DOX-PRNP2 showed better characteristics and drug release % and was hence selected to be tested in the biological study. Six different experimental groups were formed from sixty male albino mice. 1,2,-Dimethylhydrazine was used for 16 weeks to induce experimental colon cancer. We compared the oral administration of DOX-PRNP2 in doses of 5 and 10 mg/kg with the free drug. Results indicated that DOX-PRNP2 had greater antitumor activity, as evidenced by an improved histopathological picture for colon specimens as well as a decrease in the tumor scores. In addition, when compared to free DOX, the DOX-PRNP2 reduced the angiogenic indicators VEGD and CD31 to a greater extent. Collectively, the findings demonstrated that formulating DOX in PRNPs was useful in enhancing antitumor activity and can be used in other models of cancers to verify their efficacy and compatibility with our study.